Search research articles
Contact Us
Filters
Showing results (181-190 of 208) with videos related to
Page
of 21
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 12, 2023
<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior <sup>223</sup>Ra (RALU Study)
Kambiz Rahbar, Markus Essler, Matthias Eiber, et al.
Journal of Internal Medicine
|
June 26, 2025
Advanced imaging of relapse in giant cell arteritis: The role of vascular adhesion protein-1 and [<sup>68</sup>Ga]Ga-DOTA-Siglec-9 positron emission tomography-computed tomography
Simon M Petzinna, Jim Küppers, Benedikt Schemmer, et al.
Molecular Imaging and Biology
|
August 16, 2018
Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy
Rudolf A Werner, Harun Ilhan, Sebastian Lehner, et al.
Scandinavian Journal of Gastroenterology
|
July 22, 2020
Programmed cell death protein 1 (PD-1)-inhibition in hepatocellular carcinoma (HCC): a single center experience
Robert Mahn, Annabelle Vogt, Patrick Kupczyk, et al.
British Journal of Cancer
|
January 9, 2025
Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study
Joe M O'Sullivan, Daniel Heinrich, Elena Castro, et al.
Oncotarget
|
October 6, 2016
Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneity
Rudolf A Werner, Constantin Lapa, Harun Ilhan, et al.
Molecular Imaging and Biology
|
July 18, 2018
Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy
Rudolf A Werner, Harun Ilhan, Sebastian Lehner, et al.
Clinical Nuclear Medicine
|
February 1, 2023
High Interobserver Agreement on PSMA PET/CT Even in the Absence of Clinical Data
Ralph A Bundschuh, Susanne Lütje, Lena Bundschuh, et al.
La Radiologia Medica
|
March 10, 2025
Ablation of symptomatic uterine fibroids with the Mirabilis system for rapid noninvasive ultrasound-guided high-intensity focused ultrasound (HIFU): a prospective observational clinical study
Tolga Tonguc, Oleksandr Savchenko, Olga Ramig, et al.
The Journal of Urology
|
August 23, 2017
Comprehensive Evaluation of Prostate Specific Membrane Antigen Expression in the Vasculature of Renal Tumors: Implications for Imaging Studies and Prognostic Role
Sophia Spatz, Yuri Tolkach, Klaus Jung, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 208) with videos related to
Sort By:
Page
of 21
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 12, 2023
<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior <sup>223</sup>Ra (RALU Study)
Kambiz Rahbar, Markus Essler, Matthias Eiber, et al.
Journal of Internal Medicine
|
June 26, 2025
Advanced imaging of relapse in giant cell arteritis: The role of vascular adhesion protein-1 and [<sup>68</sup>Ga]Ga-DOTA-Siglec-9 positron emission tomography-computed tomography
Simon M Petzinna, Jim Küppers, Benedikt Schemmer, et al.
Molecular Imaging and Biology
|
August 16, 2018
Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy
Rudolf A Werner, Harun Ilhan, Sebastian Lehner, et al.
Scandinavian Journal of Gastroenterology
|
July 22, 2020
Programmed cell death protein 1 (PD-1)-inhibition in hepatocellular carcinoma (HCC): a single center experience
Robert Mahn, Annabelle Vogt, Patrick Kupczyk, et al.
British Journal of Cancer
|
January 9, 2025
Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study
Joe M O'Sullivan, Daniel Heinrich, Elena Castro, et al.
Oncotarget
|
October 6, 2016
Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneity
Rudolf A Werner, Constantin Lapa, Harun Ilhan, et al.
Molecular Imaging and Biology
|
July 18, 2018
Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy
Rudolf A Werner, Harun Ilhan, Sebastian Lehner, et al.
Clinical Nuclear Medicine
|
February 1, 2023
High Interobserver Agreement on PSMA PET/CT Even in the Absence of Clinical Data
Ralph A Bundschuh, Susanne Lütje, Lena Bundschuh, et al.
La Radiologia Medica
|
March 10, 2025
Ablation of symptomatic uterine fibroids with the Mirabilis system for rapid noninvasive ultrasound-guided high-intensity focused ultrasound (HIFU): a prospective observational clinical study
Tolga Tonguc, Oleksandr Savchenko, Olga Ramig, et al.
The Journal of Urology
|
August 23, 2017
Comprehensive Evaluation of Prostate Specific Membrane Antigen Expression in the Vasculature of Renal Tumors: Implications for Imaging Studies and Prognostic Role
Sophia Spatz, Yuri Tolkach, Klaus Jung, et al.
Page
of 21